Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H2N4O3.2Na |
Molecular Weight | 212.0739 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].O=C1NC2=C(NC(=O)[N-]C2=O)[N-]1
InChI
InChIKey=JNNYOCABZPYQDB-UHFFFAOYSA-L
InChI=1S/C5H4N4O3.2Na/c10-3-1-2(7-4(11)6-1)8-5(12)9-3;;/h(H4,6,7,8,9,10,11,12);;/q;2*+1/p-2
Molecular Formula | Na |
Molecular Weight | 22.98976928 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C5H4N4O3 |
Molecular Weight | 168.1103 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/25422986Curator's Comment: description was created based on several sources, including:
https://www.drugs.com/dict/uric-acid.html | http://www.wikidoc.org/index.php/Uric_acid
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25422986
Curator's Comment: description was created based on several sources, including:
https://www.drugs.com/dict/uric-acid.html | http://www.wikidoc.org/index.php/Uric_acid
Uric acid, generated from the metabolism of purines, has proven and emerging roles in human disease. Humans produce large quantities of uric acid. Excess serum accumulation of uric acid can lead to a type of arthritis known as gout. Hyperuricemia may increase risk factors for cardiovascular disease. High serum uric acid was associated with higher risk of type 2 diabetes and other diseases.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Urate oxidase (mammals) Sources: https://www.ncbi.nlm.nih.gov/pubmed/2594778 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | Unknown Approved UseUnknown |
|||
Diagnostic | Unknown Approved UseUnknown |
|||
Diagnostic | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate. | 2001 |
|
The potential role of adenosine in the pathophysiology of the insulin resistance syndrome. | 2001 Apr |
|
Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors. | 2001 Apr 9 |
|
Biochemical profile of idiopathic uric acid nephrolithiasis. | 2001 Aug |
|
Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient. | 2001 Feb |
|
A disease resembling inclusion body disease of boid snakes in captive palm vipers (Bothriechis marchi). | 2001 Jan |
|
Risk factors for coronary heart disease in obese non-diabetic subjects. | 2001 Jul |
|
Reduction of organic nitrates catalysed by xanthine oxidoreductase under anaerobic conditions. | 2001 Jul 2 |
|
Hyperuricemia and renal function. | 2001 Jun |
|
Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet. | 2001 Mar |
|
Ureteropelvic junction obstruction and coexisting renal calculi in children: role of metabolic abnormalities. | 2001 Mar |
|
Dehydroascorbic acid and oxidative stress in haemodialysis patients. | 2001 Mar |
|
Binding of urate and caffeine to haemocyanin analysed by isothermal titration calorimetry. | 2001 Mar |
|
Red wine polyphenols, in the absence of alcohol, reduce lipid peroxidative stress in smoking subjects. | 2001 Mar 15 |
|
Flavonoids and urate antioxidant interplay in plasma oxidative stress. | 2001 May |
|
Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter. | 2001 May |
|
Two types of urate binding sites on hemocyanin from the crayfish Astacus leptodactylus: an ITC study. | 2001 May 18 |
|
Intracellular pH, intrauterine growth and the insulin resistance syndrome. | 2001 Nov |
|
Urate oxidase in the prophylaxis or treatment of hyperuricemia: the United States experience. | 2001 Oct |
|
Influence of plasma glutathione levels on radiation mucositis. | 2001 Oct 1 |
|
Concentrations of nucleotides, nucleosides, purine bases, oxypurines, uric acid, and neuron-specific enolase in the cerebrospinal fluid of children with sepsis. | 2001 Sep |
|
Suicide inactivation of xanthine oxidoreductase during reduction of inorganic nitrite to nitric oxide. | 2001 Sep 1 |
|
Xanthine oxidase-derived reactive oxygen species convert flow-induced arteriolar dilation to constriction in hyperhomocysteinemia: possible role of peroxynitrite. | 2002 Jan |
|
Electrosynthesis of poly-o-diaminobenzene on the Prussian Blue modified electrodes for improvement of hydrogen peroxide transducer characteristics. | 2002 Jan |
|
Superoxide mediates shock wave induction of ERK-dependent osteogenic transcription factor (CBFA1) and mesenchymal cell differentiation toward osteoprogenitors. | 2002 Mar 29 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9435251
Mice: twice daily with 10 mg per dose for 7 days
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12743010
Uric acid (5 mg/dL) significantly increased MCP-1 production by rat vascular smooth muscle cells at 3, 6, and 24 hours when compared with that of control media.
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:44:08 GMT 2025
by
admin
on
Mon Mar 31 23:44:08 GMT 2025
|
Record UNII |
1TX0E9ZJ0W
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
134-69-0
Created by
admin on Mon Mar 31 23:44:08 GMT 2025 , Edited by admin on Mon Mar 31 23:44:08 GMT 2025
|
PRIMARY | |||
|
73456693
Created by
admin on Mon Mar 31 23:44:08 GMT 2025 , Edited by admin on Mon Mar 31 23:44:08 GMT 2025
|
PRIMARY | |||
|
DTXSID70890495
Created by
admin on Mon Mar 31 23:44:08 GMT 2025 , Edited by admin on Mon Mar 31 23:44:08 GMT 2025
|
PRIMARY | |||
|
205-152-3
Created by
admin on Mon Mar 31 23:44:08 GMT 2025 , Edited by admin on Mon Mar 31 23:44:08 GMT 2025
|
PRIMARY | |||
|
1TX0E9ZJ0W
Created by
admin on Mon Mar 31 23:44:08 GMT 2025 , Edited by admin on Mon Mar 31 23:44:08 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |